SPOTLIGHT -
CMEs 2021: A Year in Review
Psychiatric Times featured a wide variety of psychiatric issues in this year’s CMEs.
Study Shows How Patients Manage Holiday Depression
Research identifies common reasons and coping mechanisms for depression that increases during the holidays.
FDA Approves New Treatment for Bipolar Depression
Caplyta is now FDA-approved for depressive episodes from bipolar I and II.
APA, SAMHSA App Named 2021 Best Health Care Mobile Application
App allows users with serious mental illness to create and share a psychiatric advance directive.
Conference Presents Clinical Reviews and Updates
Psychiatric Times, your go-to source for what is relevant and important in the field, is pleased to share the following highlights from the 2021 Neuroscience Education Institute Congress.
Higher Rates of Anxiety, Depression Reported Among Minority Children
Research also shows increased prevalence of social risks and unmet social needs.
Study Finds Parents Are Frustrated by Lack of Mental Health Services
Survey respondents cited lack of access to services and therapists as a significant barrier to children’s mental health care.
AAP Endorses Position Statement on Restrictive Housing for Youths
Adverse effects of solitary confinement and other restrictive housing practices include higher risks of suicide among youth.
In Case You Missed It: November 22 to 26
It’s been a full week of interesting stories, commentaries, and more on a variety of topics at psychiatrictimes.com.
APA Names Recipient of the 2022 George Tarjan Award
Award honors the contributions of those who support international medical graduates.
Research Shows Magic Tricks May Boost Self-Esteem in Children and Adolescents with ADHD
Children and adolescents with ADHD often have low self-esteem. How can magic tricks help?
Nurturing Cultural Humility in Mental Health Care
How can cultural humility in therapeutic settings improve patient outcomes?
Inflamed in the Brain
What is the connection between inflammation and mood disorders?
Safety First
How do you manage the 4 most common adverse effects of antipsychotic medications?
Study Finds Psilocybin Improves MDD in Patients With Cancer
Results suggest that psilocybin therapy may prove to be helpful in improving quality of life for patients with cancer.
Study Links Large US Cities With Lower Rates of Depression
Larger cities may provide a protective buffer against developing depression.
New Study Explores Efficacy of Telehealth in Addiction Treatment
Research shows potential for increased patient engagement and limited support for improved retention rates.
New Agent for MDD, PPD Takes a Step Closer to Approval
New Drug Application to be submitted for MDD in late 2022, with separate filing for PPD planned for early 2023.
